Business · 20/11/1997

Urologix, Inc. Receives FDA Approval for T3Targeted Transurethral Thermoablation System Model 4000

The FDA has approved Urologix, Inc.'s application for premarket approval of the T3Targeted Transurethral Thermoablation System Model 4000, following a notification from the FDA's Center for Devices and Radiological Health on August 22, 1997.